Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.


Dr Pippa Corrie

Dr Corrie is the NIHR CRN National Specialty Lead for Late Phase and International Cancer Trials. She also chairs the CRN Cancer Specialty Group. If you would like to get in touch with this group please contact

Dr Corrie qualified in medicine at Oxford University, having previously undertaken a PhD in anticancer drug development. She was appointed as Consultant Medical Oncologist at Addenbrooke’s Hospital, Cambridge in 1997 and is an Associate Lecturer at the University of Cambridge.

Her specialist and research interests are in melanoma and pancreaticobiliary cancers. She chaired the NCRI Skin Cancer Clinical Studies Group from 2012-2017 and is currently the NCRI Pancreatic Cancer Clinical Studies Subgroup Chair. She is Chief Investigator of several academic and commercial-sponsored NIHR Portfolio melanoma and pancreatic cancer clinical trials.

As a melanoma specialist, she has been closely involved in the evolution of immunotherapy in research and clinical practice and has taught widely on aspects of their efficacy and toxicity management.